Roche closer to launching anaemia drug onto US market?

Roche closer to launching anaemia drug onto US market?: "Swiss drugmaker Roche moved a step closer to getting its anaemia drug Mircera onto the US market yesterday, after reportedly agreeing to terms laid out by the judge presiding over its patent infringement tussle with Amgen.

Mircera (methoxy polyethylene glycol-epoetin beta) was approved by US regulators back in November last year, but the company has been unable to launch it there because of its ongoing court battle with Amgen, which claims that the drug infringes on its intellectual property surrounding its own erythropoiesis-stimulating agents Epogen (epoetin alfa) and Aranesp (darbepoetin alfa)."